S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes

EMBO Reports

Volumn 8, Issue 5, 2007, Pages 504-509

  Saito, Taku ^a   Ikeda, Toshiyuki ^b   Nakamura, Kozo ^a   Chung, Ung Il ^b   Kawaguchi, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; LUCIFERASE; PROTEIN S100A1; PROTEIN S100B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; ENHANCER REGION; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH PLATE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

CELL DIFFERENTIATION; CELL LINE; CHONDROCYTES; DNA-BINDING PROTEINS; HELA CELLS; HIGH MOBILITY GROUP PROTEINS; HUMANS; NERVE GROWTH FACTORS; NUCLEAR PROTEINS; S100 PROTEINS; SEX-DETERMINING REGION Y PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 34247859295     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400934     Document Type: Article

References (12)

1. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813-2828
2. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98: 6698-6703
3. Du XJ, Cole TJ, Tenis N, Gao XM, Kontgen F, Kemp BE, Heierhorst J (2002) Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol 22: 2821-2829
4. Foster JW et al (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 525-530
5. Ikeda T, Kamekura S, Mabuchi A, Kou I, Seki S, Takto T, Nakamura K, Kawaguchi H, Ikegawa S, Chung UI (2004) The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50: 3561-3573
6. Lefebvre V, Li P, de Crombrugghe B (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17: 5718-5733
7. Magne D et al (2003) Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: Possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res 18: 1430-1442
8. Ng LJ, Wheatley S, Muscat GE, Conway-Campbell J, Bowles J, Wright E, Bell DM, Tam PP, Cheah KS, Koopman P (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183: 108-121
9. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, Shinomiya K, Nifuji A, Noda M (2000) SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275: 10738-10744
10. Smits P, Li P, Mandel J, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B, Lefebvre V (2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1: 277-290
11. Wagner T et al (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79: 1111-1120
12. Xiong Z, O'Hanlon D, Becker LE, Roder J, MacDonald JF, Marks A (2000) Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp Cell Res 257: 281-289